By excluding the influence of gender, age, BRAF V600E, IDH status, KPS score, methylation status of MGMT promoter, and original subtype on prognosis, the PRM is substantiated to be an independent prognostic risk factor for GBM patients. The gene discussed is MGMT; the disease is glioblastoma.